United States Diabetes Drug Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2025

1.       Report Overview

1.1.    Report Description

1.2.    Research Methods

1.3.    Research Approaches

2.       Executive Summary

3.       Market Overview

3.1.    Introduction

3.2.    Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.2.4. Challenges

3.3.    PEST-Analysis

3.4.    Porter's Diamond Model for the United States Diabetes Drug Market

3.5.    IGR-Growth Matrix Analysis

3.6.    Competitive Landscape in the United States Diabetes Drug Market

4.       United States Diabetes Drug Market by Drug Type

4.1.    Injectable Drugs

4.1.1.  Insulin

4.1.2.  Leraglutide

4.1.3.  Aspart

4.1.4.  Glargine

4.1.5.  Exenatide

4.1.6.  Pramlintide

4.2.    Oral Drugs

4.2.1.  Biguanides

4.2.2.  Sulfonylureas

4.2.3.  Meglitinides and D-phenylalanine Derivatives

4.2.4.  Thiazolidinediones

4.2.5.  DPP-4 Inhibitors

4.2.6.  Alpha-glucosidase Inhibitors

5.       United States Diabetes Drug Market by Application

5.1.    Type 1 Diabetes

5.2.    Type 2 Diabetes

6.       Company Profiles

6.1.    Company 1

6.2.    Company 2

6.3.    Company 3

6.4.    Company 4

6.5.    Company 5